Skip to content
Study details
Enrolling now

Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia

St. Jude Children's Research Hospital
NCT IDNCT07191119ClinicalTrials.gov data as of Apr 2026
Target enrollment

40

Study length

about 3.9 years

Ages

20–50

Locations

1 site in TN

What this study is about

Researchers are testing whether transcutaneous auricular vagus nerve stimulation (tVNS) can help with insomnia in adults who have survived childhood acute lymphoblastic leukemia (ALL). Participants will use a device on their ear to stimulate the vagus nerve, either actively or as a sham. The trial will measure how well people stick to using the device and see if it improves sleep quality, reduces stress, and helps with thinking skills.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Participate in Neurocognitive and mental health outcomes
  • 2.Participate in Sleep Quality
  • 3.Use Soterix tVNS device
  • +1 more

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized (Open Label)

You are randomly assigned, but you will know your treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Mean Change in Heart Rate Variability (ms)

Body systems

Oncology